In the News
K&S advises senior convertible noteholders in connection with the asset purchase agreement between Acorda Therapeutics and Merz Therapeutics
April 2, 2024
| ABF Journal

Go to the article

Explore King & Spalding
a close-up of a building
Capabilities
Mergers & Acquisitions (M&A)